Find Articles



Return to:Adhd Articles
Or:Recent Adhd Articles

Alseres Pharmaceuticals, Inc. to Present at Windhover's Therapeutic ...


http://www.forbes.com/prnewswire/feeds/prnewswire/2007/10...

Forbes - The Company has a robust molecular imaging development program targeting diagnosis of Parkinson's disease and potentially dementia and ADHD. ALTROPANE(R), the lead molecular imaging candidate, is in Phase III clinical trials for the diagnosis of ...



Article Finder:

October 18, 2007 07:13:00 AM
Article Directory